C07K 14/57572
Gastrin releasing peptide
Official title: {Gastrin releasing peptide (bombesin C07K7/086)}
C07K14/57572 (Gastrin releasing peptide) appears on 35 US grants and 26 published applications in this corpus.
Search patents in C07K- Granted patents
- 35
- Published applications
- 26
- Assignees
- 26
- Inventors
- 80
- Latest grant
- 11 Apr 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 5 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 3 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 3 |
| 2006 | 2 | 2 |
| 2007 | 0 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 1 |
| 2010 | 1 | 0 |
| 2011 | 2 | 1 |
| 2012 | 0 | 1 |
| 2013 | 2 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 2 |
| 2017 | 1 | 2 |
| 2018 | 3 | 0 |
| 2019 | 0 | 3 |
| 2020 | 1 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment11 Apr 2023US 11,623,014 B2Paul Scherrer Institut
- Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment23 Mar 2021US 10,953,114 B2Paul Scherrer Institut
- Therapeutic fusion proteins7 Jul 2020US 10,704,038 B2Ipsen Bioinnovation Limited
- Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment20 Nov 2018US 10,130,724 B2Paul Scherrer Institut
- Solid phase peptide synthesis13 Nov 2018US 10,125,163 B2CEM Corporation
- Peptide analogs and methods of using the same25 Jun 2026US 2026/0176319 A1Kallyope, Inc.
- Pharmaceutical Composition Comprising a Radiolabeled GRPR Antagonist and a Surfactant13 Jan 2022US 2022/0008566 A1Advanced Accelerator Applications International SA
- Mini-gastrin analogue, in particular for use in cck2 receptor positive tumour diagnosis and/or treatment20 May 2021US 2021/0145990 A1Paul Scherrer Institut
- Mini-gastrin analogue, in particular for use in cck2 receptor positive tumour diagnosis and/or treatment8 Aug 2019US 2019/0240360 A1Paul Scherrer Institut
- Solid phase peptide synthesis27 Jun 2019US 2019/0194246 A1CEM Corporation
Most cited
By later US patents
- Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines76US 5,759,551 AUnited Biomedical, Inc. · 1998
- Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines36US 5,843,446 AUnited Biomedical, Inc. · 1998
- Therapeutic peptides26US 5,410,019 AThe Administrators of the Tulane Educational Fund · 1995
- An octapeptide bombesin analog24US 5,084,555 ABiomeasure, Inc. · 1992
- Octapeptide bombesin analogs22US 6,307,017 B1Biomeasure, Inc. · 2001